CoChat

The Role of Renin and Angiotensin in Salt-Losing, 21- Hydroxylase-Deficient Congenital Adrenal Hyperplasia*

HORNER, JAMES M., HINTZ, RAYMOND L., LUETSCHER, JOHN A. · 1979 · The Journal of Clinical Endocrinology & Metabolism
Cited by 50

The DOI matches its Crossref record.

Abstract

Seven children with salt-losing, 21-hydroxylasedeficient congenital adrenal hyperplasia (CAH) who had been off mineralocorticoids for several years were studied before and after reinstitution of mineralocorticoid therapy. Ten children with nonsalt-losing CAH were controls. Initially, the seven subjects showed clinical evidence of poor control despite suppressive doses of hydrocortisone; five exhibited coincidental signs of glucocorticoid excess. After treatment with Florinef (0.1 mg orally twice daily) for 3 months, they reported decreased fatigue and salt craving, and four had decreased hydrocortisone requirements. There was no hypertension. Reinstitution of mineralocorticoid therapy resulted in a marked improvement in all chemical parameters measured. Serum 17-hydroxyprogesterone fell from 19,134 ± 1134 ng/dl (mean ± SEM) before treatment to 239 ± 49 ng/dl at 3 months of therapy; the control group had a level of 902 ± 318 ng/dl. PRA fell from 21.7 ± 1.9 to 2.5 ± 0.8 ng/mlh, indistinguishable from that of the control group (2.2 ± 0.7 ng/ml'h) and within normal limits. Twenty-four-hour urinary 17- ketosteroids and pregnanetriol also showed marked drops and approached normal at 3 months. Plasma ACTH levels were not elevated before or after therapy. Plasma aldosterone levels were markedly elevated initially (mean value, 55.3 ng/dl) and normalized with therapy (mean value, 17.3 ng/dl). There was a positive correlation between PRA and serum 17-hydroxyprogesterone (P < 0.001), and plasma aldosterone and serum 17-hydroxyprogesterone (P < 0.01). We thus conclude that: 1) children with 21-hydroxylase-deficient CAH can produce large amounts of aldosterone, the effects of-which are antagonized by high levels of substances such as 17-hydroxyprogesterone; 2) the renin-antiotensin system can stimulate all zones of the adrenal cortex, and elevated PRA can lead to poor control in salt-losing CAH just as can inadequate suppression of ACTH; 3) salt-losers need mineralocorticoid as well as glucocorticoid replacement for optimal control; and 4) salt losers should be maintained on mineralocorticoids for life.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem-48-5-776

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 50

Metadata

Authors
HORNER, J. M., HINTZ, R. L., & LUETSCHER, J. A.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1979-05
Volume
48
Issue
5
Pages
776-783
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1975036673
Cited by
50
References
0
FWCI
1.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of Renin and Angiotensin in Salt-Losing, 21- Hydroxylase-Deficient Congenital Adrenal Hyperplasia*. https://app.cochat.ai/papers/10.1210/jcem-48-5-776
The paper
HORNER, J. M., HINTZ, R. L., & LUETSCHER, J. A. (1979). The Role of Renin and Angiotensin in Salt-Losing, 21- Hydroxylase-Deficient Congenital Adrenal Hyperplasia*. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-48-5-776

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.